At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
SITC SITE Centers Corp.
Not Yet Opened 02-11 16:00:00 EST
6.49
-0.05
-0.76%
盘后6.49
+0.000.00%
16:32 EST
High6.59Low6.41Vol622.99K
Open6.59D1 Closing6.54Amplitude2.75%
Mkt Cap340.48MTradable Cap339.09MTotal Shares52.46M
T/O4.03MT/O Rate1.19%Tradable Shares52.25M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Site Centers Corp. to Release Fourth Quarter Earnings
Reuters  ·  05:06
Site Centers Corp. to Release Fourth Quarter Earnings
BUZZ-Curbline Properties slips after announcing stock offering
Reuters  ·  02-11 06:11
BUZZ-Curbline Properties slips after announcing stock offering
HOOKIPA Pharma Announces Sale of Oncology Assets to NeoTrail Therapeutics
GlobeNewswire  ·  02-03
HOOKIPA Pharma Announces Sale of Oncology Assets to NeoTrail Therapeutics
How Did the Trillion-Dollar Trade Surplus Arise?
Deep News  ·  01-28
How Did the Trillion-Dollar Trade Surplus Arise?
Calidi Biotherapeutics Provides Corporate Update and Key Value Drivers for 2026
GlobeNewswire  ·  01-28
Calidi Biotherapeutics Provides Corporate Update and Key Value Drivers for 2026
Press Release: SITE Centers Announces Tax Allocations of 2025 Dividend Distributions
Dow Jones  ·  01-21
Press Release: SITE Centers Announces Tax Allocations of 2025 Dividend Distributions
BRIEF-Site Centers Announces Sale Of Partnership Interests
Reuters  ·  01-17
BRIEF-Site Centers Announces Sale Of Partnership Interests
Site Centers sells RVIP IIIB joint venture interests for $20.8M
TIPRANKS  ·  01-17
Site Centers sells RVIP IIIB joint venture interests for $20.8M
Site Centers Sells Deer Park Town Center Stake for $20.8 Million
Reuters  ·  01-17
Site Centers Sells Deer Park Town Center Stake for $20.8 Million
Site Centers Corp - Sells Partnership Interests for $20.8 Mln
THOMSON REUTERS  ·  01-17
Site Centers Corp - Sells Partnership Interests for $20.8 Mln
Nurix Therapeutics Outlines 2026 Goals and Objectives for Advancing Bexobrutideg and Its Pipeline of Novel Degrader-Based Medicines in Cancer and Autoimmune Diseases
GlobeNewswire  ·  01-12
Nurix Therapeutics Outlines 2026 Goals and Objectives for Advancing Bexobrutideg and Its Pipeline of Novel Degrader-Based Medicines in Cancer and Autoimmune Diseases
BRIEF-Site Centers Announces Sale Of Perimeter Pointe
Reuters  ·  01-01
BRIEF-Site Centers Announces Sale Of Perimeter Pointe
Site Centers Sells Perimeter Pointe for $48 Million
Reuters  ·  01-01
Site Centers Sells Perimeter Pointe for $48 Million
Site Centers Announces Sale of Perimeter Pointe
THOMSON REUTERS  ·  01-01
Site Centers Announces Sale of Perimeter Pointe
Akari Therapeutics Issues 2025 End of Year Letter to Shareholders
GlobeNewswire  ·  2025-12-30
Akari Therapeutics Issues 2025 End of Year Letter to Shareholders
Site Centers Announces Sale of Downtown Short Pump
THOMSON REUTERS  ·  2025-12-12
Site Centers Announces Sale of Downtown Short Pump
Site Centers Corp - Proceeds Used to Repay $20.1 Mln Mortgage Debt
THOMSON REUTERS  ·  2025-12-12
Site Centers Corp - Proceeds Used to Repay $20.1 Mln Mortgage Debt
Site Centers Sells Downtown Short Pump for $31.5 Million
Reuters  ·  2025-12-12
Site Centers Sells Downtown Short Pump for $31.5 Million
Site Centers Corp. Boosts Severance Payouts for Key Executives After Change in Control
Reuters  ·  2025-12-05
Site Centers Corp. Boosts Severance Payouts for Key Executives After Change in Control
Site Centers Sells $3.7 Billion in Assets and Declares $380 Million in Shareholder Distributions
Reuters  ·  2025-12-05
Site Centers Sells $3.7 Billion in Assets and Declares $380 Million in Shareholder Distributions

Introduction

Company Name.
SITE Centers Corp.
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
SITE Centers is an owner and manager of open-air shopping centers located in suburban, high household income communities. The Company is a self-administered and self-managed REIT operating as a fully integrated real estate company, and is publicly traded on the New York Stock Exchange under the ticker symbol SITC.
Issue price:
--